HCA Healthcare Inc Q3 2021 Earnings Call Summary - Thomson StreetEvents

HCA Healthcare Inc Q3 2021 Earnings Call Summary

HCA Healthcare Inc Q3 2021 Earnings Call Summary - Thomson StreetEvents
HCA Healthcare Inc Q3 2021 Earnings Call Summary
Published Oct 22, 2021
20 pages (10315 words) — Published Oct 22, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of HCA.N earnings conference call or presentation 22-Oct-21 2:00pm GMT

  
Brief Excerpt:

...A. Overview: Most intense period yet for Co. with COVID pandemic. 1. Delta variant surged and drove significant demand for Co.'s services. a. 2. COVID patients accounted for 13% of total admissions. 2Q21 3%. a. b. 1Q21 10%. c. 4Q20 11%. 3. Provided record levels of inpatient care, which drove revenue growth of 15% YoverY. Inpatient revenue grew 18% and outpatient revenue grew 11%. a. 4. Vs. prior year and also 2019, same facility volumes increased across all major categories with the exception of inpatient surgery. Surgery volumes were constrained because capacity was used for treating COVID patients. a. b. Growth supported by: i. Better payer mix of commercial business. ii. Adjusted EBITDA margin was strong at over 21%. iii. Diluted EPS, excluding gains on sales of facilities, increased to $4.57, which is a notable increase over prior year even considering that 3Q20 included $1.72 per share effect of reversal of the government stimulus income, which resulted from decision to return or...

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
HCA Healthcare Inc
Ticker
HCA.N
Time
2:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Andrew Mok - UBS Investment Bank, Research Division - Analyst : First, one clarification, then I'll get to my question. Bill, earlier, I think you said 5% to 6% core EBITDA growth off of the earnings base ex government aid. If so, it sounds like you actually expect accelerating growth in 2022 compared to the long-term growth target of 4% to 6%. Is that fair?

Question: Andrew Mok - UBS Investment Bank, Research Division - Analyst : Got it. And then just a follow-up on the de novo deployment. I think you have at least 20 to 30 de novos underway between ambulatory surgery and inpatient rehab. Can you give us a sense for the cadence of when those facilities come online and the expected profit ramp in those facilities over the next 18 months?

Table Of Contents

HCA Healthcare Inc at SVB Leerink Global Healthcare (Virtual) Transcript – 2022-02-16 – US$ 54.00 – Edited Transcript of HCA.N presentation 16-Feb-22 3:40pm GMT

HCA Healthcare Inc Q4 2021 Earnings Call Summary – 2022-01-27 – US$ 54.00 – Edited Brief of HCA.N earnings conference call or presentation 27-Jan-22 3:00pm GMT

HCA Healthcare Inc Q4 2021 Earnings Call Transcript – 2022-01-27 – US$ 54.00 – Edited Transcript of HCA.N earnings conference call or presentation 27-Jan-22 3:00pm GMT

HCA Healthcare Inc at Wolfe Research Healthcare Conference (Virtual) Transcript – 2021-11-18 – US$ 54.00 – Edited Transcript of HCA.N presentation 18-Nov-21 2:50pm GMT

HCA Healthcare Inc Q3 2021 Earnings Call Transcript – 2021-10-22 – US$ 54.00 – Edited Transcript of HCA.N earnings conference call or presentation 22-Oct-21 2:00pm GMT

HCA Healthcare Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-09 – US$ 54.00 – Edited Transcript of HCA.N presentation 9-Sep-21 2:15pm GMT

HCA Healthcare Inc Q2 2021 Earnings Call Summary – 2021-07-20 – US$ 54.00 – Edited Brief of HCA.N earnings conference call or presentation 20-Jul-21 2:00pm GMT

HCA Healthcare Inc Q2 2021 Earnings Call Transcript – 2021-07-20 – US$ 54.00 – Edited Transcript of HCA.N earnings conference call or presentation 20-Jul-21 2:00pm GMT

HCA Healthcare Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript – 2021-05-19 – US$ 54.00 – Edited Transcript of HCA.N presentation 19-May-21 5:55pm GMT

HCA Healthcare Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript – 2021-05-11 – US$ 54.00 – Edited Transcript of HCA.N presentation 11-May-21 2:15pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "HCA Healthcare Inc Q3 2021 Earnings Call Summary" Oct 22, 2021. Alacra Store. May 22, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2021-HCA-Healthcare-Inc-Earnings-Call-B14995384>
  
APA:
Thomson StreetEvents. (2021). HCA Healthcare Inc Q3 2021 Earnings Call Summary Oct 22, 2021. New York, NY: Alacra Store. Retrieved May 22, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2021-HCA-Healthcare-Inc-Earnings-Call-B14995384>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.